{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:08:45Z","timestamp":1765728525436},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":292,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol Clin Exp"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1002\/hup.2447","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T08:21:38Z","timestamp":1415866898000},"page":"21-27","source":"Crossref","is-referenced-by-count":13,"title":["Are antidepressants equally effective in the long-term treatment of major depressive disorder?"],"prefix":"10.1002","volume":"30","author":[{"given":"Massimiliano","family":"Buoli","sequence":"first","affiliation":[{"name":"Department of Psychiatry; University of Milan, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Cumerlato Melter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Milan, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Caldiroli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Milan, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Carlo","family":"Altamura","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Milan, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico; Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"10.1002\/hup.2447-BIB0001|hup2447-cit-0001","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1360-0443.2010.02996.x","article-title":"A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers","volume":"105","author":"Agboola","year":"2010","journal-title":"Addiction"},{"key":"10.1002\/hup.2447-BIB0002|hup2447-cit-0002","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1742-1241.2007.01450.x","article-title":"Duration of untreated illness in major depressive disorder: a naturalistic study","volume":"61","author":"Altamura","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1002\/hup.2447-BIB0003|hup2447-cit-0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/npy.10.2","article-title":"Duration of illness and duration of untreated illness in relation to drug response in psychiatry disorders","volume":"1","author":"Altamura","year":"2011","journal-title":"Neuropsych"},{"key":"10.1002\/hup.2447-BIB0004|hup2447-cit-0004","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Revision (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/hup.2447-BIB0005|hup2447-cit-0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","article-title":"Task force on unipolar depressive disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"World J Biol Psychiatry"},{"key":"10.1002\/hup.2447-BIB0006|hup2447-cit-0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B0-08-045044-X\/00163-2","volume-title":"Comprehensive Medicinal Chemistry II","volume":"6","author":"Blackburn","year":"2007"},{"key":"10.1002\/hup.2447-BIB0007|hup2447-cit-0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S1461145705006395","article-title":"Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers","volume":"10","author":"Blier","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1002\/hup.2447-BIB0008|hup2447-cit-0008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jad.2012.07.008","article-title":"The effect of prolonged duration of untreated depression on antidepressant treatment outcome","volume":"145","author":"Bukh","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2447-BIB0009|hup2447-cit-0009","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/hup.2447-BIB0010|hup2447-cit-0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hup.1074","article-title":"Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy","volume":"25","author":"Dell'Osso","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"10.1002\/hup.2447-BIB0011|hup2447-cit-0011","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/00023210-200822070-00006","article-title":"Spotlight on bupropion in major depressive disorder","volume":"22","author":"Dhillon","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1002\/hup.2447-BIB0012|hup2447-cit-0012","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1002\/hup.2447-BIB0013|hup2447-cit-0013","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00003495-199957040-00005","article-title":"Systematic review and guide to selection of selective serotonin reuptake inhibitors","volume":"57","author":"Edwards","year":"1999","journal-title":"Drugs"},{"key":"10.1002\/hup.2447-BIB0014|hup2447-cit-0014","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I\/NP)","author":"First","year":"2002"},{"key":"10.1002\/hup.2447-BIB0015|hup2447-cit-0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jad.2009.04.016","volume":"120","author":"Gabilondo","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2447-BIB0016|hup2447-cit-0016","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/JCP.0b013e31823f705d","article-title":"Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D","volume":"32","author":"Gaynes","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.2447-BIB0017|hup2447-cit-0017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.nicl.2013.08.016","article-title":"Widespread reductions in gray matter volume in depression","volume":"3","author":"Grieve","year":"2013","journal-title":"Neuroimage Clin"},{"key":"10.1002\/hup.2447-BIB0018|hup2447-cit-0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1002\/hup.2447-BIB0020|hup2447-cit-0020","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1192\/bjp.179.42.s4","article-title":"Clinical importance of long-term antidepressant treatment","volume":"42","author":"Hirschfeld","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1002\/hup.2447-BIB0021|hup2447-cit-0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.jcp.0000150221.53877.d9","article-title":"Relapse prevention with gepirone ER in outpatients with major depression","volume":"25","author":"Keller","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.2447-BIB0022|hup2447-cit-0022","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/YIC.0b013e328314e2cb","article-title":"Assessing the efficacy of 2\u2009years of maintenance treatment with venlafaxine extended release 75-225\u2009mg\/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study","volume":"23","author":"Kornstein","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1002\/hup.2447-BIB0023|hup2447-cit-0023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1002\/hup.2447-BIB0024|hup2447-cit-0024","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/07853890.2012.705016","article-title":"Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis","volume":"44","author":"Mills","year":"2012","journal-title":"Ann Med"},{"key":"10.1002\/hup.2447-BIB0025|hup2447-cit-0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004850-199803000-00002","article-title":"Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study","volume":"13","author":"Montgomery","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1002\/hup.2447-BIB0026|hup2447-cit-0026","unstructured":"National Institute of Health and Clinical Excellence 2009 Depression in adults"},{"key":"10.1002\/hup.2447-BIB0027|hup2447-cit-0027","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jad.2009.06.044","article-title":"Canadian network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management","volume":"117","author":"Patten","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2447-BIB0028|hup2447-cit-0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-0327(02)00050-2","article-title":"Are there gender differences in major depression and its response to antidepressants?","volume":"75","author":"Scheibe","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2447-BIB0029|hup2447-cit-0029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.psc.2011.11.007","article-title":"Recovery from depression","volume":"35","author":"Stotland","year":"2012","journal-title":"Psychiatr Clin North Am"},{"key":"10.1002\/hup.2447-BIB0030|hup2447-cit-0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpsychires.2010.07.009","article-title":"Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study","volume":"45","author":"Thase","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1002\/hup.2447-BIB0031|hup2447-cit-0031","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1254\/jphs.10191FP","article-title":"Pharmacological interaction with the sigma-1 (\u03c31)-receptor in the acute behavioral effects of antidepressants","volume":"115","author":"Villard","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.1002\/hup.2447-BIB0032|hup2447-cit-0032","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2011.02.008","article-title":"Suicide in later life: a comparison between cases with early-onset and late-onset depression","volume":"132","author":"Voshaar","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1002\/hup.2447-BIB0033|hup2447-cit-0033","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","article-title":"The STAR*D Project results: a comprehensive review of findings","volume":"9","author":"Warden","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"10.1002\/hup.2447-BIB0035|hup2447-cit-0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/schbul\/sbr196","article-title":"Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research","volume":"38","author":"Wigman","year":"2012","journal-title":"Schizophr Bull"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2447","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/hup.2447\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:09:42Z","timestamp":1625162982000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2447"}},"subtitle":["ANTIDEPRESSANTS LONG-TERM TREATMENT"],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.2447","relation":{},"ISSN":["0885-6222"],"issn-type":[{"value":"0885-6222","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,13]]}}}